Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies

American Journal of Transplantation

Volumn 5, Issue 10, 2005, Pages 2433-2440

  Fabrizi, Fabrizio ^a,b   Martin, Paul ^b   Dixit, Vivek ^c   Bunnapradist, Suphamai ^c   Kanwal, Fasiha ^d,e   Dulai, Gareth ^d,e  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Diabetes mellitus; Hepatitis C virus (HCV); Meta analysis; Observational studies; Renal transplantation (RT)

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; HEPATITIS C ANTIBODY;

BODY WEIGHT; CLINICAL TRIAL; COCHRANE LIBRARY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EMBASE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT DIABETES MELLITUS; PRIORITY JOURNAL; RACE DIFFERENCE; RELIABILITY; REVIEW; SCISEARCH; SYSTEMATIC REVIEW; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; IMMUNOLOGY; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZATION; RETROSPECTIVE STUDY; RISK; TIME; TREATMENT OUTCOME;

ADULT; AGED; CASE-CONTROL STUDIES; CLINICAL TRIALS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; RANDOM ALLOCATION; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644683298     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01040.x     Document Type: Review

References (55)

1. Pereira BJG Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997 51 : 981 999.
2. Gane E Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002 74 : 427 437.
3. Vosnides GG. Nephrology Forum: hepatitis C in renal transplantation. Kidney Int 1997 52 : 843 861.
4. Fabrizi F Martin P Dixit V Bunnapradist S Dulai G. Hepatitis C virus antibody and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005 5 : 1452 1461.
5. Mathurin P Mouquet C Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999 65 : 667 670.
6. Hanafusa T Ichikawa Y Kishikawa H et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998 66 : 471 476.
7. Cruzado JM Carrera M Torras J Grinyo JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001 1 : 171 178.
8. Hestin D Guillemin F Castin N Le Faout A Champignulles J Kessler M. Pretransplant hepatitis C virus infection. A predictor of proteinuria after renal transplantation. Transplantation 1998 65 : 741 744.
9. Montori VM Basu A Erwin PJ Velosa JA Gabriel SE Kudva YC. Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 2002 25 : 583 592.
10. Miles AMV Sumrani N Horowitz R et al. Diabetes mellitus after renal transplantation. As deleterious as non-transplant-associated diabetes¿ Transplantation 1998 65 : 380 384.
11. Revanur VK Jardine AG Kingsmore DB Jaques BC Hamilton DH Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001 15 : 89 94.
12. Mason AL Lau JYN Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 29 : 328 333.
13. Caronia S Taylor K Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 30 : 1059 1063.
14. Mehta SH Brancati FL Sulkowski MS Strathdee SA Szklo M Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000 133 : 592 599.
15. AlDosary AA Ramji AS Elliott TG et al. Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transpl 2002 8 : 356 361.
16. Baid S Cosimi AB Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001 72 : 1066 1072.
17. Khalili M Lim WJ Bass N Ascher NL Roberts JP Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004 10 : 349 355.
18. Knobler H Stagnaro-Green A Wallenstein S Schwartz M Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998 26 : 30 34.
19. Batty DS Swanson SJ Kirk AD Ko CW Agodoa LY Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001 1 : 179 184.
20. Bloom RD Sayer G Fa K Constantinescu S Abt P Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005 5 : 139 144.
21. Poynard T Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of MEDLARS and manual methods. Control Clin Trials 1985 6 : 271 279.
22. The American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998 21 ( Suppl. 1 5 8.
23. DerSimonian R Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 188.
24. Gursoy M Guvener N Koksal R et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc 2000 32 : 561 562.
25. Yildiz A Tutuncu Y Yazici H et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation 2002 74 : 1109 1113.
26. Bloom RD Rao V Weng F Grossman RA Cohen D Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. Am J Soc Nephrol 2002 13 : 1374 1380.
27. Gentil MA Luna E Rodriguez-Algarra G et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002 17 : 887 891.
28. Gentil MA Lopez M Gonzalez-Roncero F et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplant Proc 2003 35 : 1748 1750.
29. Finni PES Souza ERM Rioja S et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus ¿ Transplant Proc 2004 36 : 884 885.
30. Foo SM Wong HS Morad Z. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc 2004 36 : 2139 2140.
31. Gourishankar S Jhangri GS Tonelli M Wales LH Cockfield SM. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant 2004 4 : 1876 1882.
32. Sens YAS Silva VDST Malafronte P Souza JF Miorin LA Jabur P. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant Proc 2004 36 : 886 888.
33. Gentil MA Rocha JL Pereira P Algarra GR Lopez R. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C ( letter). Nephron 1999 82 : 85.
34. Younossi ZM Braun WE Protiva DA Gifford RW Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning more than 20 years. Transplantation 1999 67 : 272 275.
35. Kasiske BL Snyder JJ Gilbertson D Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3 : 178 185.
36. Abbott KC Lentine KL Bucci JR et al. Impact of diabetes and hepatitis after kidney transplantation in patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004 15 : 3166 3174.
37. Soma J Saito T Taguma Y et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000 11 : 690 699.
38. Saxena AK Panhotra BR. The susceptibility of patient with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly 2003 133 : 611 618.
39. Miller J Mendez R Pirsch JD Jensik SC. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil in cadaveric renal transplant recipients. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. Transplantation 2000 69 : 875 880.
40. Ahsan N Johnson C Gonwa T et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation 2001 72 : 245 250.
41. Margreiter A. A prospective, randomized multicentre study to compare the efficacy and safety of tacrolimus and cyclosporin microemulsion in renal transplantation. Transplantation 2000 69 : 112.
42. Baid S Tolkoff-Rubin N Farrell ML et al. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc 2002 34 : 1771 1773.
43. Kamar N Toupance O Buchler M et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003 14 : 2092 2098.
44. Khan KS Daya S Jadad AR. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996 156 : 661 666.
45. Konrad T Zeuzem S Vicini P et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interpheron alpha. Eur J Clin Invest 2000 30 : 111 121.
46. Delgado-Borrego A Casson D Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004 77 : 703 710.
47. Narita R Abe S Kihara Y Akiyama T Tabaru A Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004 41 : 132 138.
48. Shintani Y Fujie H Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004 126 : 840 848.
49. Aytug S Reich D Sapiro LE Bernstein D Begum N. Impaired IRS-1/P13-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003 38 : 1384 1392.
50. Kawaguchi T Yoshida T Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004 165 : 1499 1508.
51. Laskus T Radkowski M Wang L Vargas H Rakela J. Search for hepatitis C virus replication sites in patients with acquired immune deficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998 28 : 1398 1401.
52. Zein NN Abdulkarim AS Wiesner RH Egan KS Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000 32 : 209 214.
53. Muzzi A Leandro G Rubbia-Brandt L et al. and the Swiss Hepatitis C Cohort Study. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005 42 : 41 46.
54. Davila JA Morgan RO Shaib Y McGlynn KA El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005 54 : 533 539.
55. Romero-Gomez M Del Mar Viloria M Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005 128 : 636 641.